Expansion of myeloid-derived suppressor cells contributes to metabolic osteoarthritis through subchondral bone remodeling.
Lixia ZhangCameron L KirkwoodJiho SohnAshley LauMary Bayers-TheringSupinder Kour BaliSridhar RachalaJohn M MarzoMark J AndersFrank BeierKeith L KirkwoodPublished in: Arthritis research & therapy (2021)
These data suggest that MDSCs are reprogrammed in metabolic disease, with the potential to contribute towards OA progression and severity.